Charity Registrdtion No. 800733 Company Registration No. 022296631England and Wales) THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION IMPROVING LIVES B Y SUPPORTING PROFESSIONALS IN THE DELIVER Y OF KIDNEY CARE & RESEARCH (A COMPANY LIMITED BY GUARANTEE) ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 UK Kidney Association *AE6U8fibJ3• II IA1510712025 -•AE5N3E¥-"- 2810612025 COMPANIES HOUSE A9
1
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) CONTENTS Page Trustees report Independent auditofs report Statement of financial acttvrties 15 Balance sheet Statement of cash flows 17 Notes to the financial'statements 18-29
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 The trustees, who are also directors of the ¢harity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2024. The trustees have adopted the provisions of Ac¢ounting and Reporting by Charities". Statement of Recommended Praclice applicable to charities prepanng their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019) and the Charities Act 2022. The finanual stalements have been prepared in accordance with the accounting policies set out in the notes to the financial statements and comply with The Renal Association's goveming document. the Companies Act 2006 and "Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Finanal Reporting Standard applicable in the UK and Republic of Ireland {FRS 102)" (effective 1 January 2019). OBJECTIVES AND ACTivinES Objectives and aims -Improving lives by supporting professionals in the delivery of kidney care and researd)" The UK Kidney Association (UKKA) is the leading professlonal body lor the UK kidney communty. We welcome members working In dinical renal care. treating and caring for people with kidney disea$8, those working in research. or related sciences and fields and all allied healthcare professionals. We are transforming the way kidney care and research is deliVed in the UK and beyond. Our decisions have been and will continue to be guided by our values". .Plaung-patients-at-the.centre of-all-decisions-we-make Effective representation of our membership and their views Celebrating differences and promoting equality W4orking in partnership with those who Share our mission Equity of access to all seNices, regardless of professional group Ensuring data is accurate and published in the public domain Using data to continually drive quality and improvement Respecting and developing our staff Leading with kindness and compassion To achieve this, we will value and support all our members from all the professlons that make us the UKKA. The UKKA can only be successfijl if each of the professional groups feel they have a valued place within rt. It is also crucial we play our part within the kidney community working with partner charities. both patient and professional facing. along statutory bodies at a national and regional level. These aims have required new structures and ways of working but are built on firm foundations of good govemance including an active and engaged group of trustees, a patient and professional council supporting and shaping Strategic decisions along with an experienced executive. ISN Fellowship Program The ISN Felli)wship Program provides an opportunity for UK units to host trainees from the developing world for up to 12 months. Since 2002, the UK ha5 hosted 30 ISN fellows based in 17 centres through the generous support of the the ISN, Kidney Researth UK and the UK Kidney Association. There is presently no ISN fellow in training.
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT {CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Strategic rnport Achievements and perfomian¢e Meetings 26 January 2024.. Renal Taster Day course. held online 15 February 2024: Intemational Case Call - hekl online 13 March 2024: Clinical Directors Forum - held at MacDonald Burtington Hotel, Birmingham 20- 22 March 2024.. BAPN I SNP Annual Meeting- held at Oxford University (Christchurch) 19April 2024.. Stewart Cameron Celebration- held at London Science Gallery (Kings Colle9e> 20- 21 April 2024.. SpR Sprin9 Meeting- held at Holiday Inn Manchester Cenlral 16- 17 May 2024.. GRID Training Day - held at Bristol University EdueAtlon Centre 11- 13 June 2024- UK Kidney Vleek- held at the EICC 8 July 2024: SpR Renal Taster.Oay- held at Engineers House Bristol 21- 22 September 2024 SpR Autumn Meeting - held at Engineers House Bristol 9- 10 October 2024.. Grid Trainin9 Day- held at Evalina Hospital London 10- 11 Oclober 2024: RPG Annual Conferen¢e- held at Arden Hotel, Bimingham 8 November 2024 PNNG Educats'onal Day- held online '12 November 2024.. Intemational Case Call- held online 15 November 2024.. Surgical Challenges - held in Glasgow 22 November 2024: Patlents Knows Best- held online 23- 24 November 2024.. Interventional Nephrology - held at Arden Hotel, Birmingham Monthly webinars and intemational case discussions. Renal Association awards and prizes Raine Av4rd The Raine award is made annually to a relatively junior member who has made a significant contribution to researth. In 2024 this was awarded to Dr Omid Sadeghi-Alavijeh. Walls Bursaries Th'e John Vklls Bursary enables two members, a dinioan and non-dinician, to spend short periods at other entres. generally outside the UK, to leam new laboratory techniques or gain new clinical skills. In 2024 no awards were offered. Lockwood Award The Lockwood Award is awarded to help members to present work and combine this wth a visit to a collaborating laboratory or clinical nephrology unit overseas. In 2024 no awards were offered.
THE RENAL ASSOCIATION TIA THE UK KluiNii Lo-" (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT {COt4TINUED)(INCLUDING DIRECTORS, REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 FSnanclal rnvlew Where our incom• ¢amo from? Our totsl income for 2024 was £5.591,721 (2023: £4,746.977) an increase of 17.8%. Income from ¢haritsble ath'vities: The majority of income is sourced from capitation fees which accounted for £2,580,919 (2023.. £2.399,401). Other income consists mainty of project worf(. sponsotship for events and a cross charge for the secretarial team (see note 4). The additional income in 2024 was from a successful UK Kidney Week, increaied RaDaR project work and additional secretarial staff (cross charge)- Income from memberships fell to a total of £149.889 (2023: £163,832), this was due mainly to operational issues wrth our website. which will be resolved in 2025. Income from scientific meetings increased to £610.261 {2023'. £383,905). this was due to record delegate registrations for UK 'dneY Week and other new events such as the Interventional Nephrology Ilvorkshop andAKI"summit. Income from donations. legacies and grants increased to £291,454 {2023'. £162,146). This was due to a large legacy which will support further educational development of healthcare professionals working in kidney disease. Income i(om inveslments= Increased to £77,858 (2023.. £44,362). This was due to high interest rates and competent investment decisions at low risk levels. Whor• vms It 8p•nt? Our total expenditure for 2024 was £5,082,416 (2023: £4,621,713) an inrJease of 10.0%. Direct CO8t8'. We 8pent £662,871 in 2024 (2023.. £624,722). Support costs.. Management Costs increased to £2,773,698 (2023.. £2.586.955) as we employed four new staff members and awarded our staff a fair cost of living increase. This also increased our human resources spend to £184,75212023. £141,069) as we supported our staff with travel and trainin9 as required. We continue to invest in our IT infrastructure lo ensure the security and integrity of our organisation, in 2024 we spent £247.857 (2023.. £211,232). Our secretariat costs increased to £366,934 12023.. £222.769) as we expanded our team. Vle have made a provision in our accounts for a non-responsive debtor of £40,000 {2023.' £6.978). this was for RaDaR project work and is a sunk cost. Grants payable decreased to £10.300 (2023: £39,703), this reduction was due to the sustainable kidney scholars project coming to fruition. For further infonnation please see notes &12. Expenditure Breakdown Sr*lC¢Jsts • IT • ProlvAiinalCor6ultants • Meetlr¢ Expws • Ollkecoss • Tre1 Financial position The UK Kidney Association had an overall surplus for 2024 of £509.294 (2023: £125.247). The assoaation had an overall surplus of £153,192 {2023: £36.835) and the UK Renal Registry had a surplus of £356.102 (2023.. £88,412). At the end of 2024 total assets held by the UKKA were £4,257,504 (2023.. £3,748.210).
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Reserves policy The trustees of the UK Kidney Association {UKKA) are obligated to act in the interests of the charity and protect and safeguard the assets with care and skill and in an accountable manner. The reserves policy has been developed by the trustees to explain to the stakeholders why we hold a particular amount of reserves. to demonstrate that finances are being properly managed and provide assuran of our overall resilience and ability to cover the winding up costs of the charity should that become necessary. The benchmark for 2024 was to hold an average of £3.9 million in re5eNe. All resenies are held either in short to medium tem investments or as cash in hand at the bank. The reserves at 3111212024 were £4.257,504 12023.. £3.748.210) which was above the benchmark. Overall, the UKKA is very secure. The reserves held are sufficient to cover 12 monihs operating costs and this should be maintained. These reseNes held fluctuate throughout the year due.to the seasonality of our income however a minimum of one year of staff salaries must be always maintained, which we adhered to for 2024. Investment policy The trustees are govemed by the Trustee Act 2000 and invest to ensure the best financial return with an acceptable level of risk and whilst still maintaining liquidity- All funds have a minimum credit rating of A- and have an ethical policy which. excludes investment in pharmaceutical companies, tobacco companies and companies involved in the production or distribution of alcohol. Fundraisin9 The chanty does not engage in significant public fundraising.
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS, REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Organlsatlonal development and future plans Developing Lèadership." Developing current and future UKKA leaders via a suite of leadership programmes Supporting national and regional leadership including national programmes Supporting all healthcare professionals who work in kidney services by.. Optimising the care that they deliver, reducing variations and conlinuously improving quality Setting high standards and enabling comparative audit of patient care and data through guidelines and the UK Renal Registry Facilitating training and utilising Quality Improvement methodolo9y SUPPOrted by KQUIP Research." Working dosely with partners within the UK Kidney Research Consortium and beyond Promoting and aiding research to reduce the burden of kidney disease and its impact on patients Investigating and evaluating services Optimising the use of available real-world data to facilitate research Wortrforce.. Monitoring the Current and future workforce requirements Engaging in shaping the future workforce Educating and developing the future workforce in response to technology and other changes working with statutory bodies to shape curriculum as well as delivering our own courses such as., UK Kidney Week ANC -Webinars-and-other"annual-conferences-for-differing" profession'al-M6iiSbersliiF> grciUPS Education.. Provision and facilitation of education to deliver Ihe best possible care for people with kidney disease Asslsting with undergraduate and postgraduate training through seminars and webinars on latest development, UK Kidney Week, Advanced Nephrology Courses and frLearning modules Quality Improvement & Assurance.. Create and support leadership within renal services by.. Enabling leaders to shape policy for kidney care services both locally and nationally Influencing kidney care nationally and intemationally Working with colleagues and partners to level up kidney care Providing optimal and sustainable kidney rAre Implementing digital solutions and empowering people living with kidney disease to access them Shaping Sernces.. Working with local commissioning services and nalional policy makers to shap8 seNice specifications Working with regional commissioning lo ensure high standards of care Campaigning nationally and locally with partners lo raise awareness of kidney disease and the services that prevent and treat it Structure. govemance and management Goveming document The charity is controlled by its goveming document. a deed of trust, and constitutes a limited company. limited by guarantee. as defined by the Companies Act 2006. The UK Kidney Associalion is a company limited by guarantee by its Memorandum and Article5 oIAssoGiation, revised in November 2020. It is registered as a tharity with the Charity Commission.
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT {CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Key management remuneration The Key Management Personnel of the Charity consists of the Chief Exetive Officer and Head of Operations. V¥Jhere such individuals or those closely connected with them are remunerated by the Charity, their pay is set by a standard salary-band matrix. Related parties None of the trustees receive remuneration or other beneffts from their work with the charity- As per the amendment in the artides, the payment of reasonable and proper fees to the employer of the President is now permitted. No payments to a president have been made to date. Related paty transactions have been disclosed in note 21. Recruitment and appointment of new tru8toes The Trustees of the Association are appoinled in a general meeting and each individual appointment shall be for a term in office as follobwa.. oslllon sidenl x2 ppoint•d lected position (ball01 f all members} orm 11 nornalty serye for five years n lolal., one a¥ Presidenl-Elect. ollowed by Of Ihree years as President, lollowed by ts¥0 or one urther years as Pa$1 President. 010 hair of Ihe Truslees. Overau slrate9i¢ leadership ol Ihe Assoaation, Chair Ihe board ol Twsiee$, UKI(A Counal ènd Professional Counul. asl Presidenl ee Pre8idenl See Presidenl $81g1s the President in carying out hislher ulies and responsibilities. Chairs Govemance nd Nominations Committee. See President hair of ihe Clinical Affairs Board, tthich co- rdinales the joint funGlions ol the.. Clinical rviees Commitiee,, Cllnical Pracb'ce Guidelines ommittee. Palienl Inform8lion Committe•'. idney Palient Salety Committee and Ihe stainable Kidne Care Committee. Chair of the AcademicAffairs Board. thich eo ordinates Ihe joint function8 ol the.. Intemalional Committee, Educabon and Training Committee. Research Committee, Renal Scientists Commillee antJ the Ra Di$ea5es Committee. ember5hip enquirtes, general erK4uirie$. mmunication wllh Ihe membership, plannlng of eetings. coor(linales UKKA responses lo nsulialions. cu)unls, contrac18, bLHJgeliThJ. Chairs Ihe Inan and Risk Committee. PwJidenl Elecl linical Vice Presidenl x 2 President lected posibon Iballol f 811 member8) e President Ill normalty serve for three ars and • maxrmum of four ears. demic Vice PresKlenl x leded posilion (ballot f all mernbersl 11 nornalty serve for Ie eafs and o maximum of four ear¥. ember3hip & Pofi ecrelbry x 2 ppoinled ty the nJslee6 11 noTmalty seNe IOT three ear8 and a maximum ol lour ear5. rnjslee with Finèncial esponstbility ppoinled by the rusiees 11 normalty serve for three ear5 and a maxirrNJm of lour ears Ill nomially serve for maximum of three years. Pre5idenl of the Bntish oc¢alion lor Paedialri¢ Ne hrol 8APN on-member Iru8lee Elecle¢J p0511ion (ballot l all paediatric embers ppoinled by the slees halo PaedialricAffairs Committee. Ill nomièlty Serve lor Ihree ea and a maximum of six ears Ill normalty seNe for the eafs and a maximum of four ears ernber ol the Finance and Risk Committeo Goveman¢x and Nominations Committee. ppointed member slees pointed by Ihe ruslees oies aThJ tr1$ to be appoinled by tr truslees.
THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED)(INCLUDING DIRECTORS, REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Induction and trainin9 of new trustees Newly elected members are advised of their responsibilities as directors and trustees via a job descripts'on. They have a period of handryover with their predecessor before formally taking up the role. Rlsk Management The trustees have a duty to identify and review the risks to whlch the chanty is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. The Finance and Risk Committee meet quarterly to review any risks, to ensure our systems are robust and to report on this risk to the trustee board. Good govemance is imbedded in our organistalion's Gutture and structure ¥vhith allows us to react swiftly when necessary. Organisational structure Founded in 1950, the UK Kidney Association is led by the Board of Trustees who work dosely wth appointed officers and members of the UKKA Council. The board of trustees meets regularfy to direct the affairs of the Charity and consull representatives from other related organisations. The Finance & Risk and Govemance & Nominats'on Committees consider their areas of focus in great detail and report recommendations and risks to the Board of Trustees. Development and management of specific dinical and academic activities is delegated to su committees who report their proceedings to the Clinical or AeAdeml¢ Affalrs Committees. Commlttees and othor bodles -The.Clinical.Affairs Board.coordinates.the-activities-of-Ihe-following committee8.'- ommlttee Nam• halr linical Sen4ices Committee Dr Marie Condon Clinical Practice Guidelines Committee Dr Mark Devonald and Ms Andrea Devaney Patient Infomation Committee Dr Yincenl Tse Patient Safety Committee r Katy Jones and Ms Karen Jenkins ustainable Kidney Care Commrttee Dr Suren Kanagasundaram and Ms Gloria Munoz- Figueroa The Academic Affairs Board coordinates the activities of the following committees.. ommittee Name hair International Committee Prof Sunil Bhandari Rare Diseases Committee rof Danny Gale Education and Training Cornmittee rof Debasish Baneriee and Dr Kate Bramham Public Benefit Statement The trustees ensure that all a¢tivits'es and future plans are in line with the Renal Association's aims and that these take into account the Charities Commission's guidance on public benefit. The trustees Confimi that they have complied with the duty in section 17{5) of the Charities Act 2022 to have regard to the Charity Commission's general guidan on public benefit, 'Charities and Publi¢ Benefit,. The charitable purposes of the Association are set out in its objectives on page 1.
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED){INCLUDING DIRECTORS, REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 REFERENCE AND ADMINISTRATIVE DETAILS Reglstsred Company number 02229663 (England and vleS) Règlstered Charlty number 800733 Registornd offico Brandon House 8uilding 20a1, Southmead Road, Filton, Bristol, BS34 7RR
THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT {CONTINUED)(INCLUDING DIRECTORS. REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 Trustees President President MDT Past President Trustee with Financial Responsibility Membership and Policy Secretary Membership and Policy Ms Linda Tann Secretary (Appointed December 2024) Co-Academic Vice President Prof John Sayer CtrAcademic Vice President Dr Kathrine Parker C(FClinical Vice President Prof James Burton Cowclinical Vice President , Ms Lisa An¢liffe BAPN President Dr Jan Dudley (R&signed June 2024) Prof Stephen Marks (Appointed July 2024) Ms Laura Meaden (Appointed September 2024) Mr Mark Froud (Appointed Seplember 2024) Mr David Silver (Resigned July 2024) Ms Heather Lawrence (Resigned Febnjary 2024) Dr Katie Vinen Ms Clare Morlid9e Prof Paul Cockwell Prof Timothy 8owen Consultant Nephrologist Consultant Phamiacist Professor of Nephrology Professor af Matrix & Molecular Biology Prof Alan Salama Professor of Nephrology Senior Project Manager Professor of Nephrology Phamacist Professor of Nephrology Occupational Therapist Paediatric Nephrologist Professor of Paediatric Nephrology Non-member Trustee Acquisitions Director Non-member Trustee Retired Professional Non-member Trustee Head of European Investment Banking Non-member Trustee Chair London Ambulance Service The Company 01Or8 ruSteeS met fomally four times in 2024 on.. 8 March, 10 June. 27 September and 4 December. They were additionally in close ¢onta¢t throughout the year, by regular email, telephone communications and scheduled fortnighuy Trustee meetings. Auditors Gravita Audit We5tem Limited, Bath House, 6-8 Bath Street, Bristol, 8S16HL The auditors will be proposed for rappOintment at the forthcoming Annual General Meets'ng. Accountants Evans & Partners Ltd. 9 Bank Road, Kingswood, Bristol, BS1 S 8LS The accountants will be proposed for re-appointment at the forthcoming Annual General Meeting Bankers Bank of Scotland Metro Bank Solicitors Blake Morgan. One Central Squa. Cardiff. CF10 1 FS
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) TRUSTEES REPORT (CONTINUED){INCLUDING DIRECTORS, REPORT AND STRATEGIC REPORT) FOR THE YEAR ENDED 31 DECEMBER 2024 statement of Trustees rosponsibillligs The trustees (who are also the directors of Th8 Renal Association for the purposes of campany lawl are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland.. Company law requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing those financial ststements, the trustees are required to select suitable accounting policies and then apply them consistently: ObSee the melhods and principles in the Chanty SORP., make judgement$ and estimates that are reasonable and prudenl". state whether applicable accounting standards have been followed. subject to any material departures disclosed and explained in the financial statemenls,, prepare the financial statements on the goin9 concern basis unless it is inappropriate to presume that the charitable company will continue in business. The trustees are responstble for keeping proper accounting records which disdose with reasonable accuracy at any time the financial position of the charitable company and to enable them lo ensure that the financial statements comply with the Companies Acl 2006. They are also responsible for safeguardin9 the assets of the charitable company and hence for taking reasonable steps lor the prevention and detection of fraud and other lffegularits'es. In so far as the trustees are aware.. there is no relevant audit infomiation of which the charitable company's auditors are unaware,. and the trustees have taken all steps that they ought to havè taken to iiiake themselves aware of any relevant audlt information and to eslabli8h that th8 auditors ara aware of that Inforniation. This report has been prepared in accordance with the specAal provisions of Part 15 of Companies Act 2006 relating to small companies. Report of the tru dire¢tors. on .... tee cgrporating a strategic report, approved by order of the board of trustees, as the company . and signed on the board's behalf by.. Professor T 8owen 10-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Opinion We have audited the financial statements of The Renal Association (the 'charitable company.) for the year ended 31 December 2024 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements. including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United 'ngdorn Generally Accepted Accounting Pra¢ti¢e>, induding Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland.. In our opinion, the ffinancial statements.. give a true and fair view of the slate of the charitable company's affairs as at 31 December 2024 and of its incoming resources and application of resources, including its income and expenditure. for the year. then ended.. have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice. including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland and have been prepared in accordance with the requirements of the Companies Act 2006. Basis for oplnion We conducted our audit in accordance with International Standard5 on Auditing {UK) (ISAS (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors, responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC'S -Ethical.Standard-. and-we-have-fulfilled our other ethical-responsibilities-in'accordance-iiiith-these requirements. We - believe that ihe audit eviden we have obtained is SLrfficient and appropriate to provide a basis for our opinion. Conclusions relating to going concem In auditing the financial statements, we have concluded that the trustees, use of the going conrn basis of accounting in the preparation of the financial slalements is appropnate. Based on the worf( we have perfomed. we have not identified any materfal uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the ¢haritable company's ability to continue as a going concem for a period of at least Iwelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the trustees with re$ped to going concem are described in the relevant sections of this report. Other information The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon. Our opinion on the financial statements does not cover the other infomation and. except to the extent otherwise explicitly staled in our report, we do not express any fomi of assurance conclusion thereon. In connedion with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misststements, we are required to detemine whether there is a material misstatement in the finanGial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. 11
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Opinions on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of our audit: the information given in the Report of the Trustees for the financlal year for which the financial statement5 are prepared is consistent with the financial statements; and the Report of the Trustees has been prepared in accordance with applicable legal requirements. Mattern on which we aro r•qulred to r8POrt by èxception In the light of the knowledge and understanding of the charitable company and ils environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees. We have nothing io report in respect of the following matters where the Companies Act 2006 requires us lo report to you rf. in our opinion.. adequate accounting records have not been kept or returns adequate for our audit have not been received from branches not Vlsited by us; or the financial statements are not in agreement with the accounting records and r8tums,' or certain disdosures of trustees, remunerats'on specified by law are not made,. or we have not received all the information and explanations we require for our audit., or the trustees were not entitled to take advantage of the small companies exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Twstees. Responsibilities of trusteos As explained. more fully in the Truslees, Responsibilities Statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of Ihe financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees detemine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the charitsble company's ability to continue as a going concem. disclosing, as applicable, matters related to going concem and using the going concem basis ot accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so. 12-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Our responsibilities for the audit of the financial ststements Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assuran, but is not a guarantee Ihat an audit conducted in accordance th ISAS (UK) will always delect a malenal misstatement when it exists. Misstalemenls can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities. including fraud, are instances of non-compliance with laws and regulations. We design prOdureS in line with our responsibilities outlined above, to detect material misstatements in respect of irregularities, including fraud. We obtained an understanding of the legal and regulatory framework applicable to the charitable company, Includin9 those areas that could reasonably be expected lo have a material effect on the financtal statements. The most significant were identified as The Companies Act 2006, UK GAAP (FRS102), The Charities SORP {FRS102) and The Chanties Act 2022. We Considered the extent of compliance with those laws and regulations as part of our procedures on the related financial statements. Our audit procedures included.. Making enquiries of management in respect to the suseeptibility and suspicion of fraud: Obtaining an understanding of the internal control structure; Closely examinlng significant unusual transactions outside the charitable companvs normal actlvlties., Substanlive testing on joumal entries for any signs of manlpulation.. -Detailed review-of accounting-eslimates;__... Agreeing a sample of employee's details to payrolllHR records and conlracts; Substantively testin9 the recognition and completeness of the charitable company's in¢cJine'streams','and ' Testing Ihe allocation of income and expenditure to the correct funds of the charitable company. 88cause of the inherent limitations of an audit, ihere ig a risk that will not detect all irregularities, induding those leadlng to a material misslatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance Vlith a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likety to become aware of instances of non-compliance. The risk is also greater regarding irregulanties occurring due to fraud rather than error, as fraud invoSves intentional concealment. fofgery, collusion, omission or misrepresentation. A further description of our responsibilities for the audit of the finanaal statements is located on the Financial Reportin9 Council's webslte at vMw.frc.org.uklauditorsresponsibilities. This description foms part of our Report of the Independent Auditors. 13-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION Use of our report This report is made Solely to the charitable company's members, as a body. in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters.we are required to state to them in an auditors, report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the tharitable company and the charitable company's members as a body. for our audit work, for this report. or for the opinions we have formed. Matlhew Bracher Bsc FCA (Senior Statutory Auditor) for and on behalf of Gravita Audit Westem Limited Chartered Accountants and Statutory Authtors 8ath House 6-8 Bath Street Bris101 BS16HL 14-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2024 Unrestricted Designated funds funds Total 2024 Total 2023 Notes Income from: Donations, legacies and grants Charilable activities Investments 115.961 1.364,772 9.458 175.493 3.857,637 68.400 291,454 162.146 5,222.409 4,540.469 77,858 44.362 Totsl Income 1.490,191 4,101,530 5,591,721 4.746.977 ndlture on: Chafltable activities Expenditure of charitable activities 1,381,300 3.701,116 5,082.418 4,621.713 Net income for tho yearl Net incoming resources 108,891 400.414 509.305 125.264 Other recognised galns and losses Other gains or losses Transfers between fund8 12 (11) (44,3011 (11) (17) 44,301 Net movèment In fund8 153,192 356,102 509,294 125.247 Fund balances at 1 January 2024 839,822 2.908,388 3,748,210 3.622,963 Fund balances at 31 Decèmber 2024 993,014 3,264,490 4,257,504 3,748,210 The statement of financial activities indudes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. The slatement of financial activities also complies with the requirements for an income and expenditure account under the Companies Act 2006. 15-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) BALANCE SHEET AS AT 31 DECEMBER 2024 2024 Total funds 2023 Total funds unre$trIct Designated funds funds Notss Fixed aèsèts Tangible assets Current assets Debtors Cash at bank and in hand 14 244 19,280 19,524 34,320 15 258,321 892.349 556,478 3,163,587 814,799 4,055,936 804,477 3,351,607 1.150,670 3,720.065 4,870.735 4,156,084 Creditors: amounts falllng due withln one. year 16 (157,900) (474,855> {832,755) (442,194) Net current assets 992,770 3,245,210 4,237.980 3,713,890 Total asvts less current liabilities 993,014 3,264.490 4,257.504 3,748.210 Incom• funds Designaled funds Unrestrlcied funds 3,264.490 993,014 2,908,388 839,822 4,257,504 3,748,210 The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2024, although an audit has been carried out under seth'on 144 of the Charlties Act 2022. The trustees a responsible ftjr ensuring that the Charity keep5 accounting records which comply with section 386 of the Act and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its incoming resources and application of fesources. including its income and expenditure, for the financial year in accordance with the requirements of sections 394 and 395. and which otheiSe comply with the requirements of the Companies Act 2006 relating to financial statements. so far as applicable to the cornpany. These financial statements have been prepared in accordance wlth the provislons applicable to companies subject to the small companies regime. The financial statements were approved by the Trustees on t>sI...4..... Professor T Bowen Trust99 Company Registrntion No. 02229663 16-
THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 2024 2023 Notes Cash flows from operating activities Cash generated from operalions 22 836.499 417.990 Cash flows from investing activities Purchase of tangible fixed assets Interest received (10,028) .77,858 (9.821) 44.362 Net cash generated from investin9 activities 67,830 34,541 Not in¢roase in cash and cash equivolenis 704.329 452,531 Cash and cash equivalents at beginnlng ol year 3,351,607 2,899,076 Cash and ca8h equlval•nts at end ol year 4,OSS,936 3,351.607 Notes to the Cash Flow Statemant 1. Analysis of changes in net debt At 01101124 Cash flow At 31112124 Net cash Cash at bank and in hand 3,351,607 704,329 4,055.936 Total 3,351.607 704,329 4,055,936 17-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policies Charity infomiation The Renal Association is a private company limited by guarantee incorporated in England and Vvales. The registered office is Brandon House Building 20a1, Southmead Road, Bristol. BS34 7RR. 1.1 Accounting convantlon The financial stslements of the charitable company, whlch is a public benefit entity under FRS102, have been prepared in accordance with the Charities SORP (FRS 102) 'Ac¢ounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance wtth the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)., Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Iland, and the Companies Act 2006. The financial statements are prepared in sterling, which is the functional currency of the Renal Association. Monetary amounts in these financial statements are rounded to the nearest'£. The finandal statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below. 1.2 Golng Concern The acLounts have been prepared on the assumption that the charitable company is able to continue as a going concem. The charitable company holds UnstrIcted, general reserves of £993.014, designated resep4es that Can be drawm down if necessary of £3,264,490 and a cash balance of £4,055,936. The trustees consider that the charitable company has suffiaent cash reserves to continue as a going coneErn for a period of at least 12 months from the date on which these financial statements are approved. 1.3 Charitable funds Unrestricted funds are used in accordance with the charitable object•ve$ at the di8cretlon of the trustees. Certain funds will be designated for specific purposes. The Executive Committee have decided that setting aside lunds in this way is a useful financial disciplin8 which will help the charity make the best use of its resources, even though there is no legal force to the desi9nation. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanats'on of the nature and purpose of each fund is induded in note 18 (movement in funds). 1A Income All income is recognised in the Statement of Financial Activitie5 once the charity has entitlement to the funds. it is probable.that the income will be received and the amount can be measured reliably. Full provision is made for subscriptions received in advance. All voluntary income is induded in income on a receipt basis. Tumover 18 measured al the fair value of the consideration received or receivable and represents amounts rec£ivable for goods and SeICe$ provided in the nomial course of business. net of discounts, VAT and other sales related tsxes. Capitation fees and grants are recognised on a receivable basis. Scientific meetings are recognised on a receipt basis when tickets for a course or event are purchased. 18-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Ac¢ounting pollcle$ (Continued) 1.$ Expenditure Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic beneffts will be required in settlement and the amount of the obligation Gan be measured reliably. Expenditure is accounted for on an accruals basis and has been dassified under headings that aggregate all cost related to the category. )OJhere costs cannot be directly attnbuted to particular headin'gs they have been allocated to activities on a basis nSIstenI with the use of resources. Grants offered subject to conditions which have not been met at the year end date are noted as a commitment bul not accrued a$ expenditure. 1.6 Tangiblo fied assets Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, nel of depreciation and any impaimient losses. Oepreciation is recogni8ed so as to write off the cost or valuation of assets le$8 their reslduai values over their useful lives on the following bases.. Computer equipment Fixtures and fittings 33% on cost 25% on cost Fixed assets are capitalised when the initial cost exceeds £500. 1.7 Financial instruments The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments, and Section 12 'Oiher Financial Instruments Issues. of FRS 102 to all of its financial instruments. Financial instruments are fecognised when the charrty becomes paty to the contractual provisions of the instrument. Financial assels and liabilities are offset. with the net amounts presented in the financial stalements, when there is a legally enforceable nght to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneou81y. Baslc flnanclal assets 8asic financial assets, which includé trade and other debtor8 and cash and bank balances. are initially measured at transaction price induding transaction costs and are subsequenuy carried at amortised cost. Financial assets are derecognised only when the contractual rights to the cash flows from the asset expl or are settled, or when the charity transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third paty. Basic financial liabilities Basic financial liabilities, including trade and other creditors are initially recognised at transaction price unless Ihe arrangement constitutes a financing transaction, where the debt inslrument is measured at the present value of the future payments discounted at a market rate of interest. Debt instruments are subsequently carried at amortised cost, using the effective interest rate methcid. Financial liabilits'es are derecognised when, and only when, the charity's contractual obligations are discharged, cancelled, or they expire. 1.8 Taxation The charity is exempt from corporation tax on its charitable activities. 19-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policles (Continued) 1.9 Employee bon¢fits The cost of any unused holiday entitlement is reco9nlsed in the period in which the employee's services are received. 1.10 Retirement benefts Payments to defined contribution retirement benefit schemes are ¢harged as an expense as they fall due. 1.11 Leases Rentals payable and receivable under operating leases are tharges to the SOFA on a straight line basis over the period of the lease. 1.12 Forelgn exchango Transactions in currencies other than pounds sterling are recorded at the rates ol exchange prevailing at the dates of the transactions. At each reporting end dale, monetary assets and liabilities that are denominated In foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in net incomel{expenditure) for Ihe period. Donatlon*. l•gacie8 and grants Unrestrlcted De8lgnated funds funds Total 2024 Total 2023 Grants Lega¢ies Donations 39,752 70,000 6,209 175.493 215.245 70,000 6,209 158,021 4,125 115,961 175,493 291,454 162,148 Grants received, Included in the above are as follows.. 2024 2023 Renal Association Unrestri¢ted Renal Reglstry Designated 39,752 175,493 45,415 112,606 215,245 158,021 -20-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Incom• from ch•r4tabl? a¢tlvltl 14lonllll¢Olh•r Sncorn•-Oi•rlorn•. R•nilA•n•l R•gl• Rifial AuoclAt Tor•1 2021 Tot41 2023 - R•MI Rotry Al1•0n 18•• Trot•41 ng1• 41 Incom• from thtIty1¢ •cllvill•i 2,560,919 149,889 610.281 604.622 1,276.718 5,222.409 4.540,489 Anaty816 by fvnd Unr•8lrided fvndi O¢•lgn•tid fvnd• 149.889 61Q.281 804,822 1,304.772 1.276,718 3.857,837 2,580,919 2,S80.919 149.889 610.261 e04,e22 1.276,718 5.222,409 For th• y1 •nded 31 D•¢•mb•r 2023 Unr•ilricled lunds D••iqnatod fvnd• 183.832 383,905 583.087 1,110,804 3,429,865 2.399,401 1.030.204 2,399.401 103,832 363.905 583,067 1,030,284 4,S40,469 21
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Other charitable activity income Unrèstricted Dasignated fund$ funds Total Total 2024 2024 2024 2023 Events Cross charge Project fees Other income 549,913 600 399,363 376.020 500.735 550,513 399,363 376,020 555,444 473,651 237.759 201,864 680.057 . 54,709 Other incorne 604,622 1,276,718 1,881,340 1,593,331 Investments Unrestrlcted Doslgnatad funds fund8 Total 2024 Total 2023 Interest receivable 9,458 68,400 77,858 44.362 Cha'rilable octlvltio8 ¢08ts Direct costs Grant funding Support costs of activities (See note 8) (See note 7) Totals Expenditure of Chairtable actlvltles 662,871 10,300 4.409,245 5,082.418 Grants payablo The total grants paid to individuals during the year was as follows: 2024 2023 Individual grants 10,300 39.703 -22-
THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Support Costs Management Finance Information technology Expenditure of Charitable activities 2,773.698 1.356 247,857 Human recources Other Govemance costs Expenditure of Charitable activities 164,752 208,786 1,012,796 Total Expenditure of Charitable activities 4,409,245 Support costs, induded in the above, are as follows.. Managemont 2024- -2023- Trustees, expenses Vvages Social security Pensions Training and Development 6,486 2,372.725 220,971 118,817 54.899 1,628 2,228,360 188.297 113,196 55,474 2,773,698 2,586,955 Finance 2024 2023 Bank charges 1,358 1.713 Infomiation technology 2024 2023 Computer.storage & advertising 247,857 211.232 -23-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Support Costs (Continued) Human resources 2024 2023 Travelling & Subsistence 164,752 141.069 Othor 2024 2023 Office Costs Postage and stationery Depreciation of tangible fixed assets Bad debt 139,277 4.685 24,824 40.000 113.993 6.380 33.391 6,978 208.786 160,742 Governance ¢osts 2024 2023 Auditors, remuneration Legal and professional Secretarial fees Accountancy and legal 6,800 628,404 366,934 10,658 6.300 614.781 222.769 11.727 1,012.796 855.577 Employee8 The average monthly number employees during the year was.. 2024 Number 2023 Number 48 44 Employment costs 2024 2023 lages and salaries Soaal security costs Other pension )Sts 2,372.725 220,971 118.617 2,228.360 188,297 113,196 2.712,313 2,529,853 -24-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Employaos Icontinuod) The number of employees whose annual renneratIOn was more than £60,000 is as follows: 2024 Number 2023 Number Employees eaming over £60.000 10 Trustse$' remuneration and b•nefits Trustees expenses are paid with accordance to The Renal Association expense daim policy. In 2024 8 tnjstees were reimbursed expenses totaling £6.486 (2023.. £1,628 reimbursed to 4 trustees). The employer of trustees (presidents) were pald 0.1 FTE in 2024, 11 Taxatlon The charlty is exempt from taxalion on itg activities because all its income is applied for charitable purpo8e8. 12__Othor..galns.or_los$e$ 2024 2023 Foreign exchange losses 11 17 -25-
THE RENALASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 13 STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2023 Unrtricted Oesignaled funds funds Total funds Income from: Donations and legacies Charitable activities Investments other income 49,540 1,110,804 6,381 112.606 3,429,665 37.981 162,146 4,540,469 44,362 Total Income 1,166,725 3.580,252 4.746.977 Ituro Charitable activities Expenditure of Charitable activities Other recognised gains and losses Transfers betweens lunds 1,173,670. 3,448,043 {17} (43,780) 4,621,713 (17) 43,780 Net Incomo1(Expondllurn) 36,835 88,412 125,247 Recon iliation nds Total funds brought forward 802,987 2,819,976 3,622,963 Total funds ¢arrled foN•ard 839,822 2,908.388 3.748,210 14 Tangiblo fixed assets Computor Flxtyres and •quipment fittlngs Total Cost At 1 January 2024 Additions 158,358 10.028 59.454 217,812 10,028 At 31 December 2024 168,386 59,454 227,840 Depreciation and impalmi•nt At 1 January 2024 Depreciation charged in the year 124,038 24,824 59,454 183,492 24,824 At 31 December 2024 148,862 59.454 208,316 Carrylng amount At 31 December 2024 19,524 19,524 At 31 December 2023 34,320 34.320 -26-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEPIIENTS (CONTINUED) FOR THE YEAR ENDED 310ECEMBER 2024 IS Debtors 2024 2023 Amounts falling due within one year: Trade debtors Purchase ledger debit balances Other debtors Prepayments and accrued income 420,640 369,761 153.528 7.854 273.334 10.340 383.819 814.799 804,477 16 Credltors: amounts lalllng duo wlthln on• year 2024 2023 Other taxation and social security Trade creditors Other creditors Accruals and deferred income 69,572 155,343 27.141 380,699 58,121 64,476 40.027 279,570 632,755 442,194 17 Retirement benèfit schome8 Dgfined contribution schemes The charity operates a defined contribution pension scheme for all qualifylng employees. The assels of the scheme are held separately from those of the tharity in an independently administered fund. The charge to profit or loss in respect of defined contribution schemes was £118,617 (2023 .' £113,196). At the year end there were pensions of £435 (2023: £15.400) deducted from salaries but not yet paid over to the pension scheme administrator.
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 18 Movement in funds. At 01101124 Net movement At 31112124 in funds Unrestrlcted funds Renal Association 839.822 153.192 993.014 Dèsignated funds Renal Registry 2,908,388 356,102 3,264,490 Totsl funds 3,748,210 509,294 4,257,504 Net movement In fund8, included in the above are a$ follows.. Incoming resources Resources expended Transfers Movement in funds Unrèstricted funds Renal Association 1,490,191 (1,381,300) 44,301 153,192 D8slgnatod fund8 Renal Reglstry 4,101.530 (3,701,127) (44,301) 356,102 Total funds 5,591.721 (5,082.427) 509,294 Dosignatèd Funds Brought foDNard Incoming resources Resources expended Carried Forward Transfers Renal Reglstry Deslgnated 2.908,388 4,101,530 (3.701,127) {44,301) 3,264,490 Total Designated Funds 2,908.388 4,101,530 (3,701.127) {44,301) 3.264.490 Funds Renal Association Fund This fvnd represents the free reserves ol the charity. Renal Registry Fund This fund represents amounts which are committed to the UK Renal Registry and have been set aside by the Executive Committee to help the Charity make best use of its resour5. Transfer of Funds During the year there was a transfer of £44.301 belween unrestricted and designated funds. This related to the transfer of the accountancy costs, the interest received in the investments bank and an outstanding invoice. -28-
THE RENAL ASSOCIATION TIA THE UK KIDNEY ASSOCIATION (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 19 Share ¢apilal The diaritable company is limited by guarantee and therefore has no share capital. Each memberfs guarantee is limited to £1. 20 Opernting lease commitments The following operating lease payments are committed to be paid as follow8.. L•nd and buildlngs 2024 2023 wthin one year Beeen and five years In over five years 48.600 182,200 48.600 192.000 38.800 230,800 279,400 21 Related party transactlon8 There were no related paty transactions in 2024 (2023.. £150). Remuneratlon of koy management per80nnel The remuneration of key management personnel is as follows. 2024 2023 Aggregate compensation 274,387 268.914 22 Cash generated from oporations 2024 2023 Surplus for the year 509,305 125.264 Adjustments for.. Investment income recognised in statement of financial activrties Foreign exchange drfferences Depreciation and impairment of tangible fixed assets (77,858) (11) 24,824 (44.362) (17) 33.391 Movements in working ¢aprtal.. (Increaselldecrease in debtOTS Increase in creditors (10,322) 190,561 245,171 58,543 Cash gènernted from opèrations 636,499 417,990 -29-